FPV Cohort (n = 105) | SQV Cohort (n = 98) | |
---|---|---|
% Male | 74% | 65% |
Mean Age (years) | 43 | 41 |
Primary HIV risk factor (%) | IVDU (53%) | IVDU (53%) |
CDC C status (%) | 44% | 34% |
Main reasons for TDF based regimen (%) | Virological failure (59%) | Virological failure (48%) |
Toxicity management (19%) | Simplification (20%) | |
Previous time on ARV; Months. Median (IQR) | 70 (21–111) | 73 (34–111) |
Most common acompanying NRTIs | 3TC or FTC (36%) | 3TC or FTC (65%) |
AZT or d4T (26%) | AZT or d4T (7%) | |
ddI (11%) | ddI (13%) | |
Median BL HIV RNA, c/mL (log) | 3.9 | 3.3 |
Mean BL CD4 count (cell/mm3) | 335 | 387 |